AUTL
Autolus Therapeutics
AUTL
AUTL
50 hedge funds and large institutions have $230M invested in Autolus Therapeutics in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
Holders
50
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.65M | |
| 2 | +$1.86M | |
| 3 | +$1.37M | |
| 4 |
Morgan Stanley
New York
|
+$1M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$665K |
Top Sellers
| 1 | -$6.39M | |
| 2 | -$5.23M | |
| 3 | -$4.13M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$3.43M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.73M |